ETS1 and hepatocellular carcinoma: To obtain a more in-depth understanding of resistance, in the present study, we investigated the mechanism of sorafenib resistance using sorafenib-resistant (soraR) HCC cells, which revealed Ets-1 to be a critical regulator of this resistant pathway.